
About NeuroEM
Our mission
At NeuroEM Therapeutics®, our mission is to revolutionize the drug-free treatment of cognitive decline through our groundbreaking Transcranial Electromagnetic Treatment, leveraging Radio Frequencies (TEMT-RF) technology. We are dedicated to translating over a decade of rigorous clinical research to develop safe, effective, and non-invasive solutions that stop and even reverse cognitive deterioration, offering hope to millions affected by neurodegenerative diseases like Alzheimer’s and those striving to maintain cognitive health throughout the aging process.
First-in-class device designed to fight Alzheimer’s
NeuroEM Therapeutics’ “first-in-class” MemorEM™ device was designed to be comfortably worn on the head to administer TEMT-RF during daily in-home treatment.
Our pioneering TEMT-RF technology has shown extraordinary promise against Alzheimer’s in all completed preclinical and clinical studies.
The electromagnetic waves emanating from multiple emitters in the wearable head cap disaggregate toxic protein ‘oligomers’ within neurons throughout the brain. Since these oligomers are increasingly believed to be the root cause of Alzheimer’s disease, we believe the MemorEM head device will directly attack the Alzheimer’s disease process.
TEMT-RF has two additional mechanisms of action that attack Alzheimer’s and other causes of cognitive decline – TEMT-RF re-balances the immune system in both brain and blood and TEMT-RF increases the energy production of brain cells.
NeuroEM’s MemorEM device will be available through neurologists and other health professionals who diagnose memory disorders once we complete our pivotal trials and receive FDA approval.
Leadership Team
-
Rob Baranowski
Sr. Engineer
Product Development -
Chuanhai Cao, MPH, PhD
Head of USF Research Team
-
Edward Goodwin, PhD
Chief Scientist
-
Tracy Ingram
Chief Information Officer
-
Patty Meagher
Community Advocate
-
Chuck Papageorgiou
Chief Executive Officer
-
Amanda Patanow
Chief Product
& Marketing Officer -
Marilyn Thompson
Chief Financial Officer
Advisors
-
Gary Arendash, PhD
Founder
& Scientist Emeritus -
William Scott Burgin, MD
Medical Advisor
-
Stephen Hull, MHS
Reimbursement Advisor
-
Kim H. Manwaring, MD
Medical Advisor
-
Lloyd Marks, MD, MBA, FACC
Medical Advisor
-
Christopher Rumana, MD
Medical Advisor
-
Johana Carolina Marisol Vega Leonel, PhD
Medical Advisor
Directors
-
Jonathan Gordon
Chairman of the Board
-
Mitch Lairmore, MBA
Director
& Proxy for Dr. Arendash -
Jamie Rutledge
Director
Partners and Collaborators
-
Left Coast Engineering
-
RF Exposure Lab
-
Ocotillo Electromagnetics
-
Remarkable Technologies
-
USF Health/Byrd Alzheimer’s Institute
-
Axiom Clinical Research of Florida
-
Invicro/Konica Minolta
-
MegaNano Biotech Inc.
-
University of South Florida